Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Questioning the role of HIPEC in patients with granulosa cell ovarian tumours.
Pleura Peritoneum
December 2024
Athens Colorectal Laboratory, Athens, Greece.
Reply to: Questioning the role of HIPEC in patients with granulosa cell ovarian tumours.
Pleura Peritoneum
December 2024
Surgical Oncology, Mercy Medical Center, Baltimore, MD, USA.
Anesthesia management of CRS and HIPEC in advanced ovarian cancer with ultra-high intra-abdominal pressure: a case report.
Front Oncol
November 2024
Department of Anesthesiology, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.
Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a leading treatment for advanced ovarian cancer, significantly improving overall survival and disease-free survival. This case involves a patient with peritoneal metastasis and ultra-high intra-abdominal pressure (36 mmHg). CRS + HIPEC induces extensive pathological and physiological changes affecting respiratory, circulatory, renal, coagulation, and metabolic systems.
View Article and Find Full Text PDFReview of Imaging Peritoneal Disease and Treatment.
Can Assoc Radiol J
December 2024
Abdominal Division, Joint Department of Medical Imaging, Toronto, ON, Canada.
Article Synopsis
- Peritoneal disease is divided into benign and malignant categories, with malignant cases further classified into primary and secondary types, including conditions like peritoneal mesothelioma and peritoneal carcinomatosis.
- Differentiating between benign and malignant peritoneal conditions is crucial, as this determines the course of treatment and helps avoid unnecessary procedures.
- For patients with secondary malignant diseases like peritoneal carcinomatosis, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) may offer a chance for cure, and radiologists play a key role in assessing disease extent and potential surgical issues.
Is there a role of cytoreductive surgery with HIPEC in recurrent ovarian granulosa cell tumors? An Indian cancer center experience with review of literature.
Indian J Cancer
January 2024
Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Article Synopsis
- Granulosa cell tumors (GCTs) are common ovarian tumors associated with a good prognosis but a tendency for late recurrences, making treatment difficult.
- A study evaluated the effects of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) on eight patients with recurrent adult GCTs, showing a median overall survival of 11.5 months post-treatment.
- The procedure demonstrated acceptable levels of postoperative complications, but more research is needed to confirm its effectiveness as a treatment option for recurrent GCTs.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!